• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

Candriam Eqs L Biotech R GBP Cap

Specialist
Price: £570.86|Change: 11.16 (-1.92%)

Pricing frequency 

Daily


Dealing cut off time 

10:45


Type 

SICAV


Yield 

–


NAV 

£570.86


Income frequency 

-


Ongoing charge 

1.1%


Latest actual NAV date 

12-11-2026


ISIN 

LU1269736911


UCITS 

Yes


Growth of 10k

Asset allocation

Top 10 holdings

Holdings 30/04/2026% of assets
Vertex Pharmaceuticals Inc4.07
Gilead Sciences Inc3.99
Alnylam Pharmaceuticals Inc3.90
Amgen Inc3.81
Regeneron Pharmaceuticals Inc3.54
Biogen Inc3.46
Insmed Inc3.07
Revolution Medicines Inc Ordinary Shares2.91
Roivant Sciences Ltd Ordinary Shares2.81
Ascendis Pharma AS2.32

Performance 31/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Fund- 1.92
Category-
More...

Investment objective

The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies from the biotechnology sector, and to outperform the benchmark. This sub-fund may be appropriate for investors who wish to achieve this objective over a long investment holding period and who are aware of, understand and are able to bear the specific risks of the sub-fund.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.


Morningstar ratingTM


Morningstar sustainability ratingTM


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.